Skip to main content
TipRanks
Go Ultimate75% OFF

William S. Caldwell Insider Profile

4 Followers

William S. Caldwell, SVP - Drug Discovery and Dev. at Gyre Therapeutics, holds 9.73K shares in Gyre Therapeutics (Ticker: GYRE).

William S. Caldwell's Trading History

GYRE
Gyre Therapeutics
Sep 29, 2011SVP - Drug Discovery and Dev.Uninformative Sell―$41.96K
GYRE
Insider Shares: 9.73K (0.09%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 29, 2011Uninformative Buy$0.00500$0.00―
Sep 29, 2011Uninformative Sell$0.001,000$0.00―
Apr 04, 2011Uninformative Sell$70.01K2,655$26.37―
Mar 02, 2011Uninformative Sell$774.27K26,841$28.84―
Feb 18, 2011Uninformative Sell$441.52K16,655$26.51―

You May Also Like

William S. Caldwell insider profile FAQ

What is the percentage of profitable transactions made by William S. Caldwell?
The percentage of profitable transactions made by William S. Caldwell is 33%.
What is the average return per transaction made by William S. Caldwell?
The average return per transaction made by William S. Caldwell is -0.60%.
What stocks does William S. Caldwell hold?
William S. Caldwell holds: GYRE stocks.
What was William S. Caldwell's most profitable transaction?
William S. Caldwell’s most profitable transaction was an Informative Sell of GYRE stock on December 14, 2010. The return on the trade was 67.40%.
What is William S. Caldwell's role in Gyre Therapeutics?
William S. Caldwell's role in Gyre Therapeutics is SVP - Drug Discovery and Dev..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.